News & Events

  • Invest­i­tions­bank Sachsen-Anhalt grants fund for Nomad´s research project „Use of non-anti­bi­otic anti­mi­cro­bial proteins (coli­cins) for control of multi resistant Escheri­chia coli (MREC)“
    (Down­load as pdf)
  • Invest­i­tions­bank Sachsen-Anhalt grants fund for Nomad´s research project „Use of non-anti­bi­otic anti­mi­cro­bial proteins (coli­cins) for control of patho­genic salmon­ellae“
    (Down­load as pdf)
  • NOMADS UAB, Lithuania Published Mile­stone Research Paper Describing its Clostridium Endolysin Product Candid­ates
    July 2018 (Down­load as pdf)
  • NOMAD Bios­cience Receives Its GRAS Regu­latory Clear­ance In USA For Plant-Made Natural Thau­matins As Sweeteners
    May 2018 (Down­load as pdf)
  • NOMAD Bios­cience Published Mile­stone Research Paper Describing its Salmocin Product Candid­ates for Control of Salmon­ella
    March 2018 (Down­load as pdf)
  • NOMADS UAB, Lithuania Published Mile­stone Research Paper Describing its Pyocin Product Candid­ates
    October 2017 (Down­load as pdf)
  • NOMAD BIOSCIENCE Completes Sale of Its Subsi­diary Icon Genetics to DENKA, Japan
    August 21, 2017 (Down­load as pdf)
  • NOMAD Bios­cience Receives Its Second GRAS Regu­latory Clear­ance In USA
    May 2017 (Down­load as pdf)
  • NOMAD Bios­cience enters into agree­ment with Monsanto
    June 2016 (Down­load as pdf)
  • NOMAD Bios­cience Receives its First Regu­latory Allow­ance in USA
    Dec 2015 (Down­load as pdf)
  • NOMAD Bios­cience Published Mile­stone Research Paper Describing its Colicin Product Candid­ates
    Sep 2015 (Down­load as pdf)
  • Denka Seiken: Announce­ment of Acquis­i­tion of Shares (Owner­ship) in ICON Genetics GmbH, a German Bio-phar­ma­ceut­ical R&D Company
    Aug 2015 (Down­load as pdf)
  • NOMAD Bios­cience Published Mile­stone Research Paper Describing its NOMADIC™ Expres­sion Tech­no­logy
    Dec 2014 (Down­load as pdf)
  • NOMAD Bios­cience and ICON Genetics sign broad cross-license agree­ment
    March 2012 (Down­load as pdf)
  • NOMAD Bios­cience enters into compre­hensive agree­ment with Bayer Innov­a­tion
    Jan 2012 (Down­load as pdf)
  • NOMAD Bios­cience announces broad license agree­ment
    Sep 2008 (Down­load as pdf)
  • NOMAD Bios­cience: new plant biotech­no­logy company founded to focus on bioma­ter­ials and biophar­ma­ceut­icals
    Sep 2008 (Down­load as pdf)